Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 438 Neoplasms 363 Breast Neoplasms 261 Colorectal Neoplasms 244 Neoplasm Metastasis 216 Melanoma 210 Leukemia, Myeloid, Acute 188 Multiple Myeloma 187 Pancreatic Neoplasms 182 Ovarian Neoplasms 181 Recurrence 175 Prostatic Neoplasms 161 Lymphoma, Non-Hodgkin 142 Stomach Neoplasms 133 Squamous Cell Carcinoma of Head and Neck 128 Lung Neoplasms 125 Lymphoma 121 Carcinoma, Hepatocellular 117 Carcinoma, Renal Cell 102 Triple Negative Breast Neoplasms 100 Leukemia, Lymphocytic, Chronic, B-Cell 99 Glioblastoma 97 Advanced Solid Tumor 94 Leukemia 93 Small Cell Lung Carcinoma 91 Lymphoma, Large B-Cell, Diffuse 90 Head and Neck Neoplasms 87 Advanced Solid Tumors 85 Endometrial Neoplasms 81 Myelodysplastic Syndromes 78

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × INDUSTRY × Advanced Liver Cancers × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡